BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 16904517)

  • 21. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer.
    Rengan R; Rosenzweig KE; Venkatraman E; Koutcher LA; Fox JL; Nayak R; Amols H; Yorke E; Jackson A; Ling CC; Leibel SA
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):741-7. PubMed ID: 15465190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
    Baumann P; Nyman J; Lax I; Friesland S; Hoyer M; Rehn Ericsson S; Johansson KA; Ekberg L; Morhed E; Paludan M; Wittgren L; Blomgren H; Lewensohn R
    Acta Oncol; 2006; 45(7):787-95. PubMed ID: 16982541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy.
    Thirion P; Holmberg O; Collins CD; O'Shea C; Moriarty M; Pomeroy M; O'Sullivan C; Buckney S; Armstrong J
    Radiother Oncol; 2004 May; 71(2):163-6. PubMed ID: 15110449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Involved-field three-dimensional conformal radiation treatment for stage III non-small-cell lung].
    Yu JM; Sun XD; Li MH; Zhang JD; Yao CP; Liu S; Zhang Z
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):526-9. PubMed ID: 17147119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.
    Werner-Wasik M; Swann RS; Bradley J; Graham M; Emami B; Purdy J; Sause W
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):385-90. PubMed ID: 17869017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
    Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
    Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer.
    Yu HM; Liu YF; Yu JM; Liu J; Zhao Y; Hou M
    Radiother Oncol; 2008 Apr; 87(1):29-34. PubMed ID: 18237795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Postoperative three-dimensional conformal radiotherapy for resected non-small cell lung cancer].
    Ji W; Wang LH; Ou GF; Liang J; Feng QF; Xiao ZF; Chen DF; Lü JM; Zhou ZM; Zhang HX; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):783-6. PubMed ID: 19173815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer.
    Sura S; Yorke E; Jackson A; Rosenzweig KE
    Cancer J; 2007; 13(4):238-42. PubMed ID: 17762758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
    Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.
    Wei X; Liu HH; Tucker SL; Liao Z; Hu C; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):100-7. PubMed ID: 16839700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation therapy for early-stage carcinoma of the oropharynx.
    Selek U; Garden AS; Morrison WH; El-Naggar AK; Rosenthal DI; Ang KK
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):743-51. PubMed ID: 15183477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy alone in elderly patients with medically inoperable stage IIIA and IIIB non-small cell lung cancer.
    Tombolini V; Bonanni A; Donato V; Raffetto N; Santarelli M; Valeriani M; Enrici RM
    Anticancer Res; 2000; 20(6C):4829-33. PubMed ID: 11205228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A matched cohort analysis of three-dimensional conformal radiotherapy versus conventional radiotherapy for primary nasopharyngeal carcinoma].
    Liu XQ; Luo W; Tang YQ; He ZC; Sun Y; Ma J; Lu TX; Liu MZ
    Ai Zheng; 2008 Jun; 27(6):606-11. PubMed ID: 18570734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner.
    Onishi H; Kuriyama K; Komiyama T; Tanaka S; Sano N; Marino K; Ikenaga S; Araki T; Uematsu M
    Lung Cancer; 2004 Jul; 45(1):45-55. PubMed ID: 15196734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy.
    Hanks GE; Hanlon AL; Pinover WH; Horwitz EM; Schultheiss TE
    Cancer J Sci Am; 1999; 5(3):152-8. PubMed ID: 10367171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer?
    McGovern SL; Liao Z; Bucci MK; McAleer MF; Jeter MD; Chang JY; O'Reilly MS; Cox JD; Allen PK; Komaki R
    Cancer; 2009 Jul; 115(14):3233-42. PubMed ID: 19472405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Late course three-dimensional conformal radiotherapy in patients with stage III non-small cell lung cancer].
    Wang XC; Wang SY; Yang S; Ding Y; Shang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):726-8. PubMed ID: 15958322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer.
    Zhang ZC; Xu J; Li BS; Zhou T; Lu J; Wang ZT; Li HS; Sun HF; Zhu J; Yu JM
    Am J Clin Oncol; 2010 Jun; 33(3):271-5. PubMed ID: 19823071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.